I 
114TH CONGRESS 
2D SESSION 
H. R. 5243 
Making appropriations for the fiscal year ending September 30, 2016, to 
strengthen public health activities in response to the Zika virus, and 
for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 16, 2016 
Mr. ROGERS of Kentucky introduced the following bill; which was referred to 
the Committee on Appropriations, and in addition to the Committee on 
the Budget, for a period to be subsequently determined by the Speaker, 
in each case for consideration of such provisions as fall within the juris-
diction of the committee concerned 
A BILL 
Making appropriations for the fiscal year ending September 
30, 2016, to strengthen public health activities in re-
sponse to the Zika virus, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
That the following sums are appropriated, out of any 
money in the Treasury not otherwise appropriated, for the 
fiscal year ending September 30, 2016, and for other pur-
poses, namely: 
VerDate Sep 11 2014 
00:30 May 17, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5243.IH
H5243
SSpencer on DSK4SPTVN1PROD with BILLS
TITLE I 
DEPARTMENT OF HEALTH AND HUMAN 
SERVICES 
CENTERS FOR DISEASE CONTROL AND PREVENTION 
CDC-WIDE ACTIVITIES AND PROGRAM SUPPORT 
(INCLUDING TRANSFER OF FUNDS) 
For an additional amount for ‘‘CDC-Wide Activities 
and Program Support’’, $170,000,000, which shall be-
come available upon enactment of this Act and remain 
available until September 30, 2016, to prevent, prepare 
for, and respond to Zika virus, domestically and inter-
nationally: Provided, That products purchased with such 
funds may, at the discretion of the Secretary of Health 
and Human Services, be deposited in the Strategic Na-
tional Stockpile under section 319F–2 of the Public 
Health Service (‘‘PHS’’) Act: Provided further, That such 
funds may be used for purchase and insurance of official 
motor vehicles in foreign countries: Provided further, That 
the provisions of section 317S of the PHS Act shall apply 
to the use of funds appropriated in this paragraph as de-
termined by the Director of the Centers for Disease Con-
trol and Prevention (‘‘CDC’’) to be appropriate: Provided 
further, That funds appropriated in this paragraph may 
be transferred by the Director of CDC to other accounts 
of the CDC for the purposes provided in this paragraph: 
VerDate Sep 11 2014 
00:30 May 17, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5243.IH
H5243
SSpencer on DSK4SPTVN1PROD with BILLS
Provided further, That of the funds appropriated under 
this heading, up to $50,000,000 may be transferred to, 
and merged with, funds appropriated under the heading 
‘‘Health Resources and Services Administration—Mater-
nal and Child Health’’ for an additional amount for the 
Maternal and Child Health Services Block Grant Program 
only for the following activities related to patient care as-
sociated with the Zika virus: prenatal care, delivery care, 
postpartum care, newborn health assessments, and care 
for infants with special health care needs: Provided fur-
ther, That such transfer authority is in addition to any 
other transfer authority provided by law: Provided further, 
That such transferred funds may be awarded notwith-
standing section 502 of the Social Security Act: Provided 
further, That such transferred funds may be awarded for 
special projects of regional and national significance to 
States, Puerto Rico, other Territories, Indian Tribes, 
Tribal Organizations and Urban Indian Organizations au-
thorized under title V of such Act: Provided further, That 
no funding provided by a grant from funds in the fifth 
proviso may be used to make a grant to any other organi-
zation or individual. 
VerDate Sep 11 2014 
00:30 May 17, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5243.IH
H5243
SSpencer on DSK4SPTVN1PROD with BILLS
NATIONAL INSTITUTES OF HEALTH 
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS 
DISEASES 
(INCLUDING TRANSFER OF FUNDS) 
For an additional amount for ‘‘National Institute of 
Allergy and Infectious Diseases’’, $230,000,000, which 
shall become available upon enactment of this Act and re-
main available until September 30, 2016, for preclinical 
and clinical development of vaccines for the Zika virus: 
Provided, That such funds may be transferred by the Di-
rector of the National Institutes of Health (‘‘NIH’’) to 
other accounts of the NIH for the purposes provided in 
this paragraph: Provided further, That such transfer au-
thority is in addition to any other transfer authority pro-
vided by law: Provided further, That such amount is des-
ignated by the Congress as an emergency requirement 
pursuant to section 251(b)(2)(A)(i) of the Balanced Budg-
et and Emergency Deficit Control Act of 1985, except that 
such amount shall be available only if the President subse-
quently so designates such amount and transmits such 
designation to the Congress. 
VerDate Sep 11 2014 
00:30 May 17, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5243.IH
H5243
SSpencer on DSK4SPTVN1PROD with BILLS